InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Glicklich Alan, Directeur Médical. Director active across 1 companies, notably Chinook Therapeutics, INC.. Aggregated, 5 reports have been recorded. The latest transaction was filed on 16 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
5,668 shares
Common Stock
SEC:0001209191-22-009563:0·
7,103 shares
Common Stock
SEC:0001209191-21-060111·
7,103 shares
Common Stock
SEC:0001209191-21-060111:0·
€7,00320,000 shares@ €0.3501100.0% of flow
Common Stock
SEC:0001209191-21-041646·
€7,00320,000 shares@ €0.350150.0% of flow
Common Stock
SEC:0001209191-21-041646:0·
5 of 5 declarations
About Glicklich Alan
Alan Glicklich is the Chief Medical Officer at Chinook Therapeutics, Inc. He oversees the company's medical and clinical activities, ensuring alignment with regulatory and ethical standards. Glicklich plays a key role in developing medical strategies and managing associated risks.
